- 专利标题： Reducing risk of contracting clostridium-difficile associated disease
-
申请号： US14798276申请日： 2015-07-13
-
公开(公告)号： US09862744B2公开(公告)日： 2018-01-09
- 发明人: Ernesto Abel-Santos , Amber Howerton
- 申请人： The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada, Las Vegas
- 申请人地址： US NV Las Vegas
- 专利权人： THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
- 当前专利权人： THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
- 当前专利权人地址： US NV Las Vegas
- 代理机构： Ballard Spahr LLP
- 主分类号： A61K31/56
- IPC分类号： A61K31/56 ; C07J41/00 ; C07J31/00
摘要：
A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.
公开/授权文献
信息查询
